Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
03/28/18	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-8.1 EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	183
03/23/18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	11
03/22/18	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	6
03/13/18	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	18
03/12/18	424B5	Prospectus filed pursuant to Rule 424(b)(5)	65
03/12/18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-5.1 EX-10.1 EX-10.2	62
03/09/18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
03/06/18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
02/28/18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
02/22/18	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	7